Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
124.96B | 127.06B | 153.33B | 148.13B | 136.16B | 140.97B | Gross Profit |
45.22B | 46.24B | 60.65B | 58.49B | 50.70B | 51.36B | EBIT |
12.60B | 13.42B | 27.11B | 28.47B | 21.90B | 19.57B | EBITDA |
19.89B | 24.65B | 36.89B | 37.57B | 30.13B | 27.35B | Net Income Common Stockholders |
10.68B | 10.44B | 20.45B | 21.19B | 17.17B | 14.96B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
52.13B | 64.65B | 64.12B | 67.06B | 62.03B | 44.09B | Total Assets |
121.05B | 250.94B | 254.17B | 243.31B | 224.67B | 198.50B | Total Debt |
15.00B | 0.00 | 0.00 | 0.00 | 0.00 | 7.23B | Net Debt |
-32.13B | -61.81B | -59.78B | -59.48B | -60.28B | -36.60B | Total Liabilities |
27.53B | 22.66B | 29.06B | 34.53B | 30.12B | 30.57B | Stockholders Equity |
93.52B | 228.16B | 224.99B | 208.66B | 194.25B | 167.59B |
Cash Flow | Free Cash Flow | ||||
6.56B | 15.54B | 2.20B | 5.53B | 22.94B | 10.65B | Operating Cash Flow |
9.83B | 30.19B | 12.99B | 15.72B | 30.87B | 22.56B | Investing Cash Flow |
-959.00M | -12.37B | -5.78B | -11.60B | -10.47B | -5.10B | Financing Cash Flow |
-1.33B | -17.15B | -7.95B | -6.51B | -4.58B | -3.99B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
$1.50B | 19.88 | 4.82% | 3.40% | ― | ― | ||
66 Neutral | $4.51B | 12.29 | 5.40% | 248.53% | 4.14% | -12.41% | |
$1.95B | 14.95 | 6.35% | 1.98% | ― | ― | ||
€1.15B | 8.62 | 8.48% | 4.41% | ― | ― | ||
€1.32B | 11.73 | 14.03% | 2.61% | ― | ― | ||
78 Outperform | ¥154.20B | 11.36 | 3.48% | 15.78% | 62.07% | ||
74 Outperform | ¥240.45B | 19.89 | 1.35% | 16.07% | 61.09% |